ÐÇ¿Õ´«Ã½

The Diversity Engagement Survey (DES) completed by School of Medicine faculty, staff and students last year provided important insights toward the goal of building a strong community that inspires trust and responds to concerns. Developed by the University of Massachusetts Medical School and the Association of American Medical Colleges, the DES…

ÐÇ¿Õ´«Ã½ one of 16 best medical schools for research ÐÇ¿Õ´«Ã½ School of Medicine is among the country’s top medical schools for research, according to the annual listing from U.S. News & World Report. For its 2025 ratings, the publication drastically adjusted its methodology—forgoing its typical…

Reda Riffi, a first-generation student at ÐÇ¿Õ´«Ã½, was selected to participate in the BioMed Amgen Scholars Program at Yale University this summer. Riffi is majoring in neuroscience and conducts research at ÐÇ¿Õ´«Ã½ in the Xiong Lab.

There’s only one U.S. Food and Drug Administration-approved therapy for an inherited retinal disease, and dozens of retinitis pigmentosa (RP) genes for which no therapy is available.

As a future physician, Devin Barzallo wants to promote healthy equity and improve healthcare access for marginalized communities. The American Medical Association Foundation has taken note of Barzallo's commitment to serving vulnerable and underserved populations—awarding him the Underrepresented in Medicine Physicians of Tomorrow Scholarship of $…

Rachel Gardenhire, a third-year medical student at ÐÇ¿Õ´«Ã½, has been selected to take part in the 2024 NFL Diversity in Sports Medicine Pipeline Initiative, which aims to inspire medical students from various backgrounds to consider pursuing careers in sports medicine.

In 2014, Amy Wilson-Delfosse—serving as the president of the International Association of Medical Science Educators (IAMSE)—had the privilege of presenting the inaugural Edward Patrick Finnerty Lifetime Achievement Award to its namesake, E. Patrick Finnerty. Ten years later, the roles were reversed as Finnerty bestowed the honor on her at the…

With a new five-year, $2.78 million grant from the National Institutes of Health and National Cancer Institute, researchers at ÐÇ¿Õ´«Ã½ (ÐÇ¿Õ´«Ã½), Cleveland Clinic and University Hospitals (UH) will use artificial intelligence (AI) to better treat rectal cancer patients.

Sreelakshmi Vasudevan is focused on helping people keep their sight. Originally from Kerala, India, Vasudevan is a postdoctoral scholar in ÐÇ¿Õ´«Ã½ School of Medicine’s Department of Ophthalmology and Visual Sciences working alongside Paul Park.

Exceptional staff members recognized for distinguished service and volunteerism ÐÇ¿Õ´«Ã½ staff members play a pivotal role in the university’s success, contributing to every aspect of campus life. Our employees are the backbone of the university—their dedication to areas from administrative support to academic guidance to facilities…

To our School of Medicine community, In the 41 years that Nathan Berger, MD, provided academic leadership at ÐÇ¿Õ´«Ã½ and University Hospitals, he, arguably, had the greatest impact on medicine in Cleveland of anyone—creating, evolving, nurturing, advising and championing ideas, careers and organizations.  Now, we are…

For Tiffany Vaughan, there are many pathways for healing hearts.  The rising fourth-year ÐÇ¿Õ´«Ã½ School of Medicine student, who plans to specialize in cardiology, has the opportunity to bring contemporary meaning to the atrocities of Nazi Germany. Through a Fellowship at Auschwitz for the Study of Professional Ethics…

New study finds ‘AMPLON’ method offers faster, more accurate pathogen identification, even in complex DNA sequences A team of researchers from the ÐÇ¿Õ´«Ã½ School of Medicine has developed a new method for target DNA sequence amplification, testing and analysis.

A new study by researchers at the ÐÇ¿Õ´«Ã½ School of Medicine reveals that the popular diabetes and weight-loss drugs Wegovy and Ozempic are linked to reduced incidence and recurrence of alcohol abuse or dependence.